Current Trials

ACCELERATE study — hydroxyurea adoption research

Study One

mAnaging siCkle CELl disEase through incReased AdopTion of hydroxyurEa in Nigeria (ACCELERATE) Study

ClinicalTrials.gov - NCT 06318143

Sponsor

NIH (National Institute of Health, USA)

Study Type

Pragmatic Implementation Study

Sites

16 sites across Nigeria

MPIs

Emmanuel Peprah, PhD

Obiageli Nnodu, MD

Primary Objective

To evaluate the level of hydroxyurea (HU) adoption among healthcare providers of our task-sharing (SIM) intervention in Nigeria and determine if HU adoption improved patient-level Sickle Cell Disease management and outcomes.

iCTS Role

Trial Monitor